Immatics N.V. (IMTX) Financials

IMTX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 623.2 million 100.3 million
Dec. 31, 2025 659.9 million 91.8 million
Sept. 30, 2025 715.0 million 140.5 million
June 30, 2025 668.7 million 121.1 million

IMTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -49.9 million ?
Dec. 31, 2025 -68.8 million 3.9 million
Sept. 30, 2025 -53.7 million 3.8 million
June 30, 2025 -47.9 million 4.9 million

IMTX Net Income

No data available :(

IMTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 520.3 million - 14.3 million
Dec. 31, 2025 550.8 million - 15.1 million
Sept. 30, 2025 594.1 million - 18.6 million
June 30, 2025 563.6 million - 20.2 million

IMTX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 154.3 million
Dec. 31, 2025 148.0 million
Sept. 30, 2025 142.7 million
June 30, 2025 143.3 million

IMTX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 888743 68.9 million 13.7 million -
Dec. 31, 2025 1.1 million 58.3 million 16.0 million -
Sept. 30, 2025 1.3 million 55.4 million 14.9 million -
June 30, 2025 1.8 million 53.2 million 15.1 million -

IMTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 8.9 million -
Dec. 31, 2025 23.2 million -
Sept. 30, 2025 6.1 million -
June 30, 2025 5.6 million -

IMTX

Price: $9.38

52 week price:
5.05
12.41

Earnings Per Share: -2.00 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Germany

Volume: 207152

Market Capitalization: 1.3 billion

Links: